Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2005-11-01
2005-11-01
Park, Hankyel T. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S008000, C435S008000, C435S832000, C435S832000, C424S159100
Reexamination Certificate
active
06960431
ABSTRACT:
Methods for inhibiting viral propagation and treating viral infection are provided which include administering to cells infected with viruses a therapeutic peptide or a derivative thereof.
REFERENCES:
patent: 5807995 (1998-09-01), Cohen et al.
patent: 5891668 (1999-04-01), Li et al.
patent: 5892016 (1999-04-01), Brie et al.
patent: 6248523 (2001-06-01), Cohen et al.
patent: 6251629 (2001-06-01), Warren
patent: 6274312 (2001-08-01), Gish et al.
patent: 2003/0049607 (2003-03-01), Greener et al.
patent: WO 02/094314 (2002-11-01), None
patent: WO 03/033646 (2003-04-01), None
patent: WO 03/046176 (2003-06-01), None
patent: WO 03/051835 (2003-06-01), None
Parent, Leslie J., et al., “Positionally Independent and Exchangeable Late Budding Functions of the Rous Sarcoma Virus and Human Immunodeficiency Virus Gag Proteins”,Journal of Virology, Sep. 1995; 69(9):5455-5460.
NCBI Entrez Protein Database Accession No.: AAB38034, Dec. 5, 1996.
Zhang, Yi-Ming, et al., “Drug Resistance during Indinavir Therapy Is Caused by Mutations in the Protease Gene and in Its Gag Substrate Cleavage Sites”,Journal of Virology, Sep. 1997; 71(9):6662-6670.
Puffer, Bridget A., et al., “Equine Infectious Anemia Virus Utilizes a YXXL Motif within the Late Assembly Domain of the Gag p9 Protein”,Journal of Virology, Sep. 1997; 71(9):6541-6546.
NCBI Entrez Protein Database Accession No.: AAB83138, Nov. 6, 1997.
NCBI Entrez Protein Database Accession No.: AAB83216, Nov. 6, 1997.
NCBI Entrez Protein Database Accession No.: AAB83821, Nov. 6, 1997.
Yasuda, Jiro, et al., “A Proline-Rich Motiff (PPPY) in the Gag Polyprotein of Mason-Pfizer Monkey Virus Plays a Maturation-Independent Role in Virion Release”,Journal of Virology, May 1998; 72(5):4095-4103.
NCBI Entrez Protein Database Accession No.: P35962, Jul. 15, 1998.
Crump, Colin M., et al., “Inhibition of the Interaction between Tyrosine-based Motifs and the Medium Chain Subunit of the AP-2 Adaptor Complex by Specific Tyrphostins”,The Journal of Biological Chemistry, Oct. 23, 1998; 273(43):28073-28077.
Puffer, Bridget A., et al., “Equine Infectious Anemia Virus Gag Polyprotein Late Domain Specifically Recruits Cellular AP-2 Adapter Protein Complexes during Virion Assembly”,Journal of Virology, Dec. 1998; 72(12):10218-10221.
Sorkina, Tatiana, et al., “Clathrin, adaptors and eps15 in endosomes containing activated epidermal growth factor receptors”,Journal of Cell Science, 1999; 112:317-327.
Yuan, Bing, et al., “Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle”,The EMBO Journal, 1999; 18(17):4700-4710.
NCBI Entrez Protein Database Accession No.: AAD03232, Jan. 6, 1999.
NCBI Entrez Protein Database Accession No.: AAD03240, Jan. 6, 1999.
Garnier, Laurence, et al., “Identification of Retroviral Late Domains as Determinants of Particle Size”,Journal of Virology, Mar. 1999; 73(3):2309-2320.
Harty, Ronald N., et al., “A Proline-Rich Motif within the Matrix Protein of Vesicular Stomatitis Virus and Rabies Virus Interacts with WW Domains of Cellular Proteins: Implications for Viral Budding”,Journal of Virology, Apr. 1999; 73(4):2921-2929.
Craven, Rebecca C. et al., “Late Domain Function Identified in the Vesicular Stomatitis Virus M Protein by Use of Rhabdovirus-Retrovirus Chimeras”,Journal of Virology, Apr. 1999; 73(4):3359-3365.
Harvey, Kieran F., et al., “Nedd4-like proteins: an emerging family of ubiquitin-protein ligases implicated in diverse cellular functions”,Trends in Cell Biology, May 1999; 9:166-169.
Deschambeault, Julie, et al., “Polarized Human Immunodeficiency Virus Budding in Lymphocytes Involves a Tyrosine-Based Signal and Favors Cell-to-Cell Viral Transmission”,Journal of Virology, Jun. 1999; 73(6):5010-5017.
NCBI Entrez Protein Database Accession No: AAF35354, Feb. 23, 2000.
Alexander, Louis, et al., “Unusual Polymorphisms in Human Immunodeficiency Virus Type 1 Associated with Nonprogressive Infection”,Journal of Virology, May 2000; 74(9):4361-4376.
Butkiewicz, Nancy, et al., “Virus-Specific Cofactor Requirement and Chimeric Hepatitis C Virus/GB Virus B Nonstructural Protein 3”Journal of Virology, May 2000; 74(9):4291-4301.
Accola, Molly A., et al., “Efficient Particle Production by Minimal Gag Constructs Which Retain the Carboxy-Terminal Domain of Human Immunodeficiency Virus Type 1 Capsid-p2 and a Late Assembly Domain”,Journal of Virology, Jun. 2000; 74(12):5395-5402.
Yuan, Bing, et al., “Infectivity of Moloney Murine Leukemia Virus Defective in Late Assembly Events Is Restored by Late Assembly Domains of Other Retroviruses”,Journal of Virology, Aug. 2000; 74(16):7250-7260.
NCBI Entrez Protein Database Accession No.: CAB92786, Sep. 20, 2000.
Jayakar, Himangi R., et al., “Mutations in the PPPY Motif of Vesicular Stomatitis Virus Matrix Protein Reduce Virus Budding by Inhibiting a Late Step in Virion Release”,Journal of Virology, Nov. 2000; 74(21):9818-9827.
Strack, Bettina, et al., “A role for ubiquitin ligase recruitment in retrovirus release”,PNAS, Nov. 21, 2000; 97(24):13063-13068.
Schubert, Ulrich, et al., “Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2”,PNAS, Nov. 21, 2000; 97(24):13057-13062.
Patnaik, Akash, et al., “Ubiquitin is part of the retrovirus budding machinery”,PNAS, Nov. 21, 2000; 97(24):13069-13074.
Vogt, Volker M., “Ubiquitin in retrovirus assembly: Actor or bystander?”,PNAS, Nov. 21, 2000; 97(24):12945-12947.
Harty, Ronald N., et al., “A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding”,PNAS, Dec. 5, 2000; 97(25):13871-13876.
Ikeda, Masato, et al., “PY Motifs of Epstein-Barr Virus LMP2A Regulated Protein Stability and Phosphorylation of LMP2A-Associated Proteins”,Journal of Virology, Jun. 2001; 75(12):5711-5718.
NCBI Entrez Protein Database Accession No.: AAD17020, Jun. 1, 2001.
Verplank, Lynn, et al., “Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag”,PNAS, Jul. 3, 2001; 98(14):7724-7729.
Garrus, Jennifer E., et al., “Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 Budding”,Cell, Oct. 5, 2001; 107:55-65.
Li, Feng, et al., “Functional Replacement and Positional Dependence of Homologous and Heterologous L Domains in Equine Infectious Anemia Virus Replication”,Journal of Virology, Feb. 2002; 76(4):1569-1577.
Strack, Bettina, et al., “AIP/ALIX is a Binding Partner for HIV-1 p6 an EIAV p9 Functioning in Virus Budding”,Cell, Sep. 19, 2003; 114:1-20.
Hobden Adrian
Morham Scott
Zavitz Kenton
Gibbs Andrew
Myriad Genetics Inc.
Myriad IP Dept.
Park Hankyel T.
Zhang Jay Z.
LandOfFree
Therapeutic compositions and methods for treating viral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compositions and methods for treating viral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compositions and methods for treating viral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3452830